Atlas Trials

Exploratory Study of OPC-12759 Ophthalmic Suspension

Clinical trial NCT01493180 · COMPLETED

Trial details

NCT number
NCT01493180
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Keratoconjunctival Epithelial Disorder
Start date
2011-12-01
Primary completion
2012-11-01
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.